摘要
The pharmaceutical sector in China is shifting fromchaotic to standardized in order and hidden to evi-dent in rule. The production is getting more andmore concentrated. Leading companies still hold astrong position. Biological medicines and famous-brand/modern Chinese medicines are sectors withprominent comparative advantage and will remainto be investment focuses in 2007 and 2008.There is only development trendbut no real performancein conventional
